Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Analysts cut enGene cancer sales forecast after updated data widen gap to J&J

Analysts cut enGene cancer sales forecast after updated data widen gap to J&J

  • May 8, 2026

Leerink Partners analysts slashed their sales forecast for enGene Therapeutics’ bladder cancer candidate after phase 2 data dented their belief that the biotech can match rivals including Johnson & Johnson.

Leave A Comment

Fields (*) Mark are Required